HMD
HERAMED FPO [HMD]
Healthcare · ASX Small Cap
$0.0380 +0.0%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +4First seen: 2026-02-25
Score Breakdown
Technical58
Catalyst53
Sentiment50
Fundamental20
Momentum66
Risk Gate30
Active Signals
Bullish Signals
- Above 200-day MA (long-term uptrend)
- Critical cash runway (0.9 quarters)
- Very high P/S ratio (131.0x)
- Revenue in sharp decline (-23%)
- Small-cap ($20-100M)
- Strong 12-1 momentum (+165%)
- Altman Z-Score in distress zone (1.52 < 1.81)
- Low-priced stock risk ($0.038)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Piotroski F-Score weak (3/9)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Revenue momentum declining (-23%)
Recent Catalysts
NONE Appendix 4G and Corporate Governance Statement
NONE Preliminary Final Report
NONE Letter to Shareholders, Notice of EGM & Proxy Form
LOW Annual Report to shareholders
LOW Investor Presentation
Recent ASX Announcements
| 2026-02-26 | Appendix 4G and Corporate Governance Statement |
| 2026-02-26 | Annual Report to shareholders |
| 2026-02-26 | Preliminary Final Report PRICE SENSITIVE |
| 2026-02-25 | Investor Presentation |
| 2026-02-23 | Letter to Shareholders, Notice of EGM & Proxy Form |
Key Metrics
$42.3M
Market Cap
463K
Avg Volume
0.8x
Vol Ratio
$0.01 — $0.05
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-518.4%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 64% |
| L | Leader vs Laggard | laggard | RS: 0 |
| I | Institutional Sponsorship | weak | Inst: 4% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #110 of 119 · Sector avg: 51
View all Healthcare signals →